Disease

Congenital generalized lipodystrophy type 31, 2, 3

Gene

CAV1

Inheritance AR and AD
Current Treatments metreleptin, Tirzepatide
Evidence for Treatment expert opinion
Non-Molecular Testing Availability yes
Non-Molecular Test leptin level4
Disease Frequency (per 100,000) 0.0235
Genes Included in Disease Frequency AGPAT2, BSCL2, CAV1, CAVIN1
Experimental / Investigational Therapies https://clinicaltrials.gov/ct2/results?cond=Generalized+Lipodystrophy&term=&cntry=&state=&city=&dist=
Last Updated: March 5, 2026
RX Genes
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.